| dc.contributor.author | Morales, Jose | en_US |
| dc.contributor.author | Lopez, Ruth | en_US |
| dc.contributor.author | Lopez, Jorge | en_US |
| dc.contributor.author | Lozano, Jair | en_US |
| dc.contributor.author | Jarillo, Rosa | en_US |
| dc.contributor.author | Flores, Hector | en_US |
| dc.contributor.author | Castillo, Enrique | en_US |
| dc.date.accessioned | 1399-07-09T08:24:45Z | fa_IR |
| dc.date.accessioned | 2020-09-30T08:24:45Z | |
| dc.date.available | 1399-07-09T08:24:45Z | fa_IR |
| dc.date.available | 2020-09-30T08:24:45Z | |
| dc.date.issued | 2020-08-01 | en_US |
| dc.date.issued | 1399-05-11 | fa_IR |
| dc.date.submitted | 2019-12-04 | en_US |
| dc.date.submitted | 1398-09-13 | fa_IR |
| dc.identifier.citation | Morales, Jose, Lopez, Ruth, Lopez, Jorge, Lozano, Jair, Jarillo, Rosa, Flores, Hector, Castillo, Enrique. (2020). Left ventricular phosphorylation patterns of Akt and ERK1/2 after triiodothyronine intracoronary perfusion in isolated hearts and short-term <i>in vivo</i> treatment in Wistar rats. Iranian Journal of Basic Medical Sciences, 23(8), 1091-1099. doi: 10.22038/ijbms.2020.44776.10451 | en_US |
| dc.identifier.issn | 2008-3866 | |
| dc.identifier.issn | 2008-3874 | |
| dc.identifier.uri | https://dx.doi.org/10.22038/ijbms.2020.44776.10451 | |
| dc.identifier.uri | http://ijbms.mums.ac.ir/article_15831.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/340914 | |
| dc.description.abstract | <em><strong>Objective(s):</strong></em> To determine the effects of triiodothyronine (T3) intracoronary perfusion in isolated hearts and short-term administration in rats on the left ventricular (LV) phosphorylation patterns of Akt and ERK1/2. <br /><em><strong>Materials and Methods:</strong></em> Cardiodynamic and hemodynamic parameters were evaluated in Langendorff–perfused hearts. Left ventricles were used for histomorphometric and Western blot analyses. Short-term hyperthyroidism was established by T3 (500 μg.kg-1.d-1; subcutaneous injection) for 1 (T31d), 3 (T33d), and 10 (T310d) days. <br /><em><strong>Results:</strong></em> Isolated hearts receiving T3 perfusion did not modify LV developed pressure, +dP/dtmax, -dP/dtmin, heart rate, and coronary perfusion pressure compared with vehicle-perfused hearts. P-ERK1/2 and p-Akt levels in LV tissues after 5, 15, or 60 min of T3 or vehicle perfusion were similar. Compared with their time-matched controls, isolated hearts of T33d and T310d rats exhibited LV hypertrophy and increased absolute values of +dP/dtmax and -dP/dtmin (i.e., positive inotropic and lusitropic effects). P-ERK1/2 decreased in LV tissues of T31d and T310d but not in those of T33d rats, and p-Akt levels augmented in left ventricles of T33d and stayed unaltered in those of T31d and T310d rats.<br /><em><strong>Conclusion:</strong></em> T3 intracoronary perfusion did not alter cardiodynamics and hemodynamics nor influence the activation of Akt and ERK of normal hearts. Accordingly, the rapid non-genomic effects of T3 were not evident. Short-term T3 treatment provoked cardiac hypertrophy coincidental with increased LV function and associated with transient Akt activation and cyclic ERK1/2 inhibition; which implies activation of physiological hypertrophy signaling and deactivation of pathological hypertrophy signaling, respectively. | en_US |
| dc.format.extent | 1263 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | Mashhad University of Medical Sciences | en_US |
| dc.relation.ispartof | Iranian Journal of Basic Medical Sciences | en_US |
| dc.relation.isversionof | https://dx.doi.org/10.22038/ijbms.2020.44776.10451 | |
| dc.subject | Akt ERK1 | en_US |
| dc.subject | 2 Heart hypertrophy Rat Triiodothyronine treatment | en_US |
| dc.title | Left ventricular phosphorylation patterns of Akt and ERK1/2 after triiodothyronine intracoronary perfusion in isolated hearts and short-term <i>in vivo</i> treatment in Wistar rats | en_US |
| dc.type | Text | en_US |
| dc.type | Original Article | en_US |
| dc.contributor.department | Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México | en_US |
| dc.contributor.department | Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México | en_US |
| dc.contributor.department | Departamento de Biología Celular, Instituto Nacional de Perinatología, Ciudad de México, México | en_US |
| dc.contributor.department | Departamento de Biología Celular, Instituto Nacional de Perinatología, Ciudad de México, México | en_US |
| dc.contributor.department | Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México | en_US |
| dc.contributor.department | Departamento de Inmuno-Bioquímica, Instituto Nacional de Perinatología, Ciudad de México, México | en_US |
| dc.contributor.department | Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de México, México | en_US |
| dc.citation.volume | 23 | |
| dc.citation.issue | 8 | |
| dc.citation.spage | 1091 | |
| dc.citation.epage | 1099 | |
| nlai.contributor.orcid | 0000-0003-0150-1352 | |
| nlai.contributor.orcid | 0000-0001-7857-1215 | |
| nlai.contributor.orcid | 0000-0002-0298-3173 | |
| nlai.contributor.orcid | 0000-0003-1962-5097 | |
| nlai.contributor.orcid | 0000-0002-7604-6158 | |
| nlai.contributor.orcid | 0000-0001-8436-2276 | |